Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
NCT ID:
NCT05300412
Eligibility Criteria:
Inclusion Criteria:
* Patients with invasive breast cancer, confirmed with biopsy
* Operable and without distant metastases.
Exclusion Criteria:
* Patients with acute and/or chronic inflammatory diseases, rheumatoid disease and other malignancies occurring simultaneously
* Patients receiving immune modulatory therapy
* Patients previously treated by surgery, chemotherapy, radiotherapy, target therapy or endocrine therapy
* Patients with dementia or any other psychological disorders unable to willingly participate in the study.
Exclusion Criteria for the control group:
* Breast tumors or any other confirmed malignancies
* Any acute or chronic inflammatory disease
* Receiving immune modulatory therapy
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT05300412
Study Brief:
Protocol Section:
NCT05300412